Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly. | EGEMS (Wash DC);7(1): 46, 2019 Aug 26. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

BVS - MINISTÉRIO DA SAÚDE

Informação e Conhecimento para a Saúde

português

Localizar descritor de assunto Busca Avançada EVID@Easy

Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly.

McCormick, Thomas A; Adams, John L; Lee, Eric A; Emptage, Nicholas P; Palmer-Toy, Darryl E; Martin, John P; Broder, Benjamin I; Kanter, Michael H; Davis, Anna C; McGlynn, Elizabeth A.

Afiliação

McCormick TA; Kaiser Permanente Center for Effectiveness & Safety Research, US.
Adams JL; Kaiser Permanente Center for Effectiveness & Safety Research, US.
Lee EA; Southern California Permanente Medical Group, US.
Emptage NP; Kaiser Permanente Center for Effectiveness & Safety Research, US.
Palmer-Toy DE; Southern California Permanente Medical Group, US.
Martin JP; Southern California Permanente Medical Group, US.
Broder BI; Southern California Permanente Medical Group, US.
Kanter MH; Kaiser Permanente School of Medicine, US.
Davis AC; Kaiser Permanente Center for Effectiveness & Safety Research, US.
McGlynn EA; Kaiser Permanente School of Medicine, US.

EGEMS (Wash DC) ; 7(1): 46, 2019 Aug 26.

Article em En | MEDLINE | ID: mdl-31523695

Palavras-chave

Chronic Illness; Clinical Practice Pattern; Diabetes Mellitus; Electronic Health Record; Quality Improvement; Quality of Care

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article